MARKET

GRI

GRI

GRI Bio
NASDAQ
1.818
-0.042
-2.26%
Opening 12:04 06/30 EDT
OPEN
1.870
PREV CLOSE
1.860
HIGH
1.870
LOW
1.722
VOLUME
25.82K
TURNOVER
--
52 WEEK HIGH
80.36
52 WEEK LOW
1.720
MARKET CAP
3.22M
P/E (TTM)
-0.0208
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at GRI last week (0622-0626)?
Weekly Report · 1d ago
Weekly Report: what happened at GRI last week (0615-0619)?
Weekly Report · 06/22 09:15
GRI Bio Secures FDA Orphan Drug Status for IPF
TipRanks · 06/18 23:11
GRI Bio announces U.S. FDA granted ODD to GRI-0621
TipRanks · 06/18 13:05
GRI Bio Says FDA Grants Orphan Drug Designation To GRI-0621 For Treatment Of Idiopathic Pulmonary Fibrosis, Irreversible And Ultimately Fatal Lung Disease
Benzinga · 06/18 12:34
GRI Bio wins FDA orphan drug designation for GRI-0621 in pulmonary fibrosis
PUBT · 06/18 12:31
GRI BIO SECURES FDA ORPHAN DRUG DESIGNATION FOR GRI-0621 (TAZAROTENE) IN IDIOPATHIC PULMONARY FIBROSIS
Reuters · 06/18 12:31
GRI Bio granted FDA orphan designation for tazarotene
TipRanks · 06/17 15:00
More
About GRI
Vallon Pharmaceuticals Inc is a provider of biotechnology research and development services. The Company is located in Philadelphia, Pennsylvania.

Webull offers GRI Bio Inc stock information, including NASDAQ: GRI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GRI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GRI stock methods without spending real money on the virtual paper trading platform.